Cyber espionage targeting biotech companies

Introduction

Cyber espionage targeting biotechnology companies refers to the unauthorized use of digital technologies, cyberattacks, and covert information-gathering activities to obtain confidential scientific, commercial, technological, and research-related information from biotechnology organizations. Such activities may be conducted by foreign intelligence agencies, competing businesses, organized cybercriminal groups, or other unauthorized actors.

Biotechnology companies possess valuable intellectual property, including genetic research, pharmaceutical formulations, vaccine development data, clinical trial results, biological manufacturing processes, and artificial intelligence-based drug discovery technologies. This information has considerable scientific, commercial, and strategic value. Consequently, biotechnology organizations have become attractive targets for cyber espionage.

Cyber espionage may involve unauthorized access to research databases, theft of confidential documents, ransomware attacks, manipulation of scientific records, phishing, insider threats, and attacks against cloud-based research infrastructure.

From a legal perspective, cyber espionage raises questions concerning data protection, intellectual property, national security, corporate responsibility, international cybersecurity cooperation, and criminal liability. Governments must establish effective legal mechanisms to protect biotechnology innovation while ensuring that cybersecurity measures respect privacy and fundamental rights.

Nature and methods of cyber espionage in biotechnology

Cyber espionage generally involves the unauthorized collection, transfer, or exploitation of confidential information through digital systems.

Biotechnology companies may face several forms of cyber threats.

1. Intellectual property theft

Attackers may attempt to obtain unpublished research, laboratory protocols, genetic engineering information, pharmaceutical formulations, and proprietary manufacturing processes.

Such information can provide competitors with an unfair commercial advantage and undermine years of scientific investment.

2. Phishing and social engineering

Cyber attackers may send fraudulent emails or messages to employees, researchers, and laboratory administrators to obtain confidential login credentials or unauthorized access to organizational systems.

3. Database intrusion

Unauthorized access to internal research databases may expose clinical trial records, genomic datasets, patient information, and proprietary scientific findings.

4. Cloud-based espionage

Biotechnology companies increasingly use cloud platforms for storing experimental data, research documentation, and computational models. Weak access controls may expose sensitive information to unauthorized individuals.

5. Insider threats

Employees, contractors, consultants, or research collaborators may misuse legitimate access privileges to obtain confidential information and transfer it to unauthorized parties.

6. Supply-chain cyberattacks

Attackers may compromise software providers, laboratory equipment suppliers, research institutions, or external service providers to gain indirect access to biotechnology companies.

Legal framework governing cyber espionage

1. Information Technology Act, 2000

The Information Technology Act, 2000, is India's principal legislation addressing several forms of cybercrime and unauthorized digital activity.

Section 43 provides for compensation where a person, without permission, accesses computer systems, downloads or copies information, introduces contaminants, disrupts systems, or performs other specified unauthorized acts.

Section 66 provides criminal punishment for specified acts under Section 43 when committed dishonestly or fraudulently.

Section 66B addresses receiving stolen computer resources or communication devices.

Section 66C deals with identity theft, including fraudulent use of electronic signatures, passwords, or other unique identification features.

Section 66D addresses cheating by personation using computer resources.

Section 70 protects notified protected systems against unauthorized access, while Section 70B establishes CERT-In as the national agency for specified cybersecurity incident-response functions.

Section 72 addresses breach of confidentiality and privacy by persons exercising powers under the Act, while Section 72A addresses disclosure of personal information in breach of a lawful contract, subject to statutory requirements.

These provisions may apply when cyber espionage involves unauthorized access, theft of digital information, identity misuse, or unlawful disclosure of confidential information.

2. Digital Personal Data Protection Act, 2023

The Digital Personal Data Protection Act, 2023, establishes obligations concerning the processing and protection of digital personal data.

Biotechnology companies frequently process sensitive operational information alongside personal information belonging to patients, clinical trial participants, employees, and research volunteers.

Organizations must implement appropriate security safeguards and comply with applicable breach-related obligations under the Act and its rules.

The Act is particularly relevant where cyber espionage exposes identifiable personal information through compromised research databases or clinical trial systems.

3. Indian Penal Code and Bharatiya Nyaya Sanhita, 2023

The Bharatiya Nyaya Sanhita, 2023, replaced the Indian Penal Code with effect from 1 July 2024.

Depending on the circumstances, provisions concerning cheating, forgery, criminal breach of trust, and related offences may become relevant to cyber espionage activities.

Where conduct occurred before the commencement of the new legislation, the applicable substantive criminal law must be determined according to the relevant transitional and savings provisions.

4. National Cyber Security Policy, 2013

India's National Cyber Security Policy seeks to protect information infrastructure and strengthen national cybersecurity capabilities.

Its objectives include:

Protecting critical information infrastructure.

Strengthening cybersecurity awareness.

Encouraging public-private cooperation.

Developing cybersecurity skills and expertise.

Improving incident response mechanisms.

Promoting secure information-sharing practices.

Biotechnology companies involved in strategically important research may benefit from implementing these cybersecurity principles.

5. Protection of intellectual property rights

Cyber espionage frequently involves the unauthorized acquisition of trade secrets, research documents, patented inventions, and confidential manufacturing information.

The Patents Act, 1970, protects eligible inventions through patent rights, while the Copyright Act, 1957, protects original software, databases to the extent they qualify as protected works, and scientific documentation.

Confidential business information and trade secrets may receive protection through contractual obligations, equitable principles of confidentiality, and other applicable legal remedies.

India does not currently have a single comprehensive standalone trade secrets statute.

International legal framework

1. Budapest Convention on Cybercrime, 2001

The Budapest Convention provides an international framework for addressing computer-related offences.

It covers offences involving illegal access, illegal interception, data interference, system interference, and misuse of devices.

It also establishes mechanisms for international cooperation and electronic evidence preservation.

India is not a party to the Convention, although its principles remain relevant when examining international cybersecurity cooperation.

2. Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), 1994

Article 39 of TRIPS requires protection of undisclosed information against unfair commercial use and unauthorized disclosure, acquisition, or use contrary to honest commercial practices.

This provision is particularly relevant to biotechnology companies because their confidential research information, manufacturing methods, and commercial strategies may constitute protected undisclosed information.

3. Convention on Biological Diversity, 1992

The Convention on Biological Diversity recognizes the importance of biological resources, conservation, and the fair and equitable sharing of benefits arising from their utilization.

Cyber espionage involving genetic resources and associated traditional knowledge may raise additional questions concerning unauthorized access, confidentiality, and benefit-sharing obligations.

4. United Nations Convention against Transnational Organized Crime, 2000

The Convention establishes an international cooperation framework for combating organized transnational criminal activities.

Its relevance arises where cyber espionage forms part of organized criminal activity involving multiple countries, subject to the Convention's scope and applicable legal requirements.

Important judicial decisions and case laws

1. Shreya Singhal v. Union of India (2015)

The Supreme Court of India examined the constitutional validity of Section 66A of the Information Technology Act, 2000.

The Court struck down Section 66A because it violated the freedom of speech and expression guaranteed under Article 19(1)(a) of the Constitution.

Relevance: The judgment establishes that cybersecurity regulation must remain consistent with constitutional freedoms. Measures adopted against cyber espionage should have a proper legal basis and should not unnecessarily restrict legitimate scientific communication or research activities.

2. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017)

The Supreme Court recognized privacy as a fundamental right under Article 21 of the Constitution.

The judgment established important principles concerning informational privacy, individual autonomy, and protection of personal information.

Relevance: Biotechnology companies handling genomic information, clinical trial records, and patient data must respect privacy rights and implement appropriate safeguards against unauthorized access and disclosure.

3. Syed Asifuddin v. State of Andhra Pradesh (2005)

The Andhra Pradesh High Court considered allegations involving unauthorized alteration of electronic identification information associated with mobile handsets.

The judgment examined the application of the Information Technology Act to unauthorized electronic manipulation.

Relevance: The case illustrates the importance of protecting electronic systems and digital information against unauthorized interference. Similar principles may apply to the protection of biotechnology research infrastructure.

4. Avnish Bajaj v. State (NCT of Delhi) (2008)

The Delhi High Court considered criminal liability arising from the circulation of objectionable material through an online platform.

The proceedings examined the responsibilities of individuals associated with digital platforms and the application of the Information Technology Act.

Relevance: The decision is useful when examining the responsibilities of companies and individuals involved in managing digital information systems. Biotechnology companies must establish appropriate governance and access-control procedures to prevent misuse of their platforms.

5. Anvar P.V. v. P.K. Basheer (2014)

The Supreme Court examined the admissibility of electronic records under the Indian Evidence Act, 1872.

The judgment emphasized compliance with statutory requirements for proving electronic evidence.

Relevance: Cyber espionage investigations depend heavily on digital evidence, including system logs, emails, access records, and electronic communications. Biotechnology companies should preserve relevant digital records to support investigations and legal proceedings.

The evidentiary framework has subsequently been replaced by the Bharatiya Sakshya Adhiniyam, 2023.

Corporate liability and responsibilities of biotechnology companies

Biotechnology companies have an important responsibility to protect their research infrastructure and confidential information.

Their responsibilities may arise from statutory obligations, contractual commitments, intellectual property rights, and applicable regulatory requirements.

Important corporate measures include:

Implementing multi-factor authentication and strong access controls.

Encrypting confidential research databases and communications.

Conducting regular cybersecurity audits.

Maintaining secure backups of scientific and clinical research records.

Establishing employee cybersecurity training programmes.

Monitoring unusual access to proprietary research information.

Maintaining incident-response and breach-reporting procedures.

Reviewing cybersecurity protections of external vendors and research partners.

Companies should also establish confidentiality agreements with employees, consultants, laboratories, and research collaborators.

Challenges in prosecuting cyber espionage

Cyber espionage involving biotechnology companies presents several legal and technical challenges.

1. Attribution difficulties: Attackers may operate through compromised systems and multiple international networks, making identification difficult.

2. Jurisdictional conflicts: Research databases and cloud servers may be located in different countries, creating complex jurisdictional questions.

3. Evidence preservation: Digital evidence may be modified, deleted, or transferred before investigators can secure it.

4. Intellectual property valuation: Determining the commercial value of stolen scientific research can be difficult.

5. State-sponsored activities: Cyber operations involving foreign government actors may raise questions of state responsibility, sovereign immunity, and international law.

6. Privacy concerns: Cybersecurity investigations must balance the protection of confidential business information with the privacy rights of employees, patients, and research participants.

Preventive measures and regulatory recommendations

Effective prevention requires cooperation between biotechnology companies, cybersecurity professionals, government agencies, and international institutions.

The following measures are particularly important:

Establishing industry-specific cybersecurity standards for biotechnology research.

Developing secure repositories for genomic and clinical research data.

Strengthening CERT-In coordination and incident-reporting mechanisms.

Introducing regular penetration testing and vulnerability assessments.

Protecting intellectual property through technical and contractual safeguards.

Improving international cooperation for cross-border cybercrime investigations.

Developing specialized cyber forensic capabilities for biotechnology-related incidents.

Establishing clear accountability for third-party research and cloud service providers.

Conclusion

Cyber espionage targeting biotechnology companies represents a serious threat to scientific innovation, commercial confidentiality, public health infrastructure, and national technological security. Unauthorized access to genetic databases, pharmaceutical research, clinical trial records, and proprietary biological manufacturing processes can cause substantial economic and scientific damage.

In India, the Information Technology Act, 2000, Digital Personal Data Protection Act, 2023, intellectual property legislation, and applicable criminal laws provide important legal mechanisms for addressing different aspects of cyber espionage.

International instruments such as TRIPS, the Budapest Convention, and the United Nations Convention against Transnational Organized Crime provide additional principles for protecting confidential information and strengthening international cooperation.

Judicial decisions concerning privacy, electronic evidence, cybersecurity regulation, and digital responsibility help establish the legal principles applicable to these challenges.

Ultimately, biotechnology companies must adopt strong cybersecurity governance, protect confidential research information, maintain reliable digital evidence, and cooperate with regulatory authorities. Effective legal protection combined with technological safeguards is essential for preserving scientific innovation and maintaining trust in the biotechnology sector.